My first introduction to the BREP program was in the spring of 2001 as part of a campus tour for admitted high school seniors. I had declared my major of Chemical Engineering and a facility tour concluded in the Bioprocess Scale-Up Facility (BSF). I introduced myself to the facility’s manager, Ben Woodard, and asked if he was hiring any part-time undergrad lab assistants. Ben asked me to leave me some contact information and he would be in touch if anything became available. Ben followed up with me a few weeks later and asked if I would be interested in starting work at the BSF that summer. I could not have answered, “yes” any quicker. More importantly, I did not realize that Ben had just offered a position to me that would single-handedly open doors leading to the position I have today – leading the Gene Therapy Manufacturing Sciences Group at Biogen. My experience as an undergrad working at the BSF taught me two key lessons: (1) a job in the biotechnology industry is a tight-knit community that values internships (2) supplementing textbook information with practical biopharmaceutical knowledge leads you to rewarding career opportunities. I spent all five undergraduate years at the BSF gaining critical knowledge under the leadership of Ben. He taught me how to steam sterilize a fermenter, pack a chromatography column, lyophilize a recombinant protein, and probably more importantly, why it is important to show up to work on time, communicate effectively, and how to present yourself professionally. After spending almost 5 years at a local vaccine development and manufacturing company, I returned to the BREP program in 2011 to lead a newly commissioned core facility focused on mammalian cell culture production and purification. The position created a platform for me to grow as a manager, hiring full-time research staff and the critically important undergraduate researchers. The staff and I created industrial workshops, training biopharmaceutical professionals on cell culture techniques, eventually evolving into a workshop on viral vector manufacturing strategies. We produced and purified viral vectors for critical pre-clinical gene therapy studies, developed scale-down production models for commercial monoclonal antibody platforms and built stronger connections for the University of Maryland to NIST and the FDA. The investments the University made to furnish the lab with modern equipment, upgrade supporting laboratory facilities, and build a trained work staff created a pillar of success for the BREP program in one of the most important biopharmaceutical regions in the world – the 270 corridor in Montgomery County. I left the BREP program to join Biogen in 2017, but will never forget the lasting impact the BREP program has made on me and my family. The BREP program was a key catalyst in my career and personal development. As a BREP employee, the program offered a platform to drive innovation and education in the highly dynamic field of gene therapy. As a BREP student, the program offered key connections in the industry, invaluable training programs, and a place to grow as a future employee of the biotechnology industry. Most importantly, the state of Maryland is lucky to have Ben as a key asset to foster education, technology advancement, and mentorship to future and current students, employees, and employers. --John Kerwin